Co reminds me of MyoKardia ..eventually bt out by BMS I think
Early days
Kiwi
Recent TNYA News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2024 08:15:46 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2024 08:09:36 PM
- Tenaya Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update • GlobeNewswire Inc. • 05/14/2024 08:05:00 PM
- Tenaya Therapeutics to Highlight Growing Capabilities in Capsid Engineering, Gene Editing and Manufacturing at the American Society of Gene and Cell Therapy 27th Annual Meeting • GlobeNewswire Inc. • 05/02/2024 09:00:00 PM
- Tenaya Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update • GlobeNewswire Inc. • 03/18/2024 08:05:00 PM
- Tenaya Therapeutics Announces Publication of TN-401 Gene Therapy Preclinical Data in Nature Communications Medicine • GlobeNewswire Inc. • 03/18/2024 12:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/28/2024 12:30:20 AM
- Tenaya Therapeutics to Participate in Upcoming March Investor Conferences • GlobeNewswire Inc. • 02/27/2024 09:30:00 PM
- Tenaya Therapeutics Announces Publication of Preclinical HDAC6 Inhibitor Data for Heart Failure with Preserved Ejection Fraction in Nature Communications • GlobeNewswire Inc. • 02/26/2024 01:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/17/2024 01:35:42 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/17/2024 01:13:18 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 02/08/2024 10:25:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/08/2024 01:15:02 PM
- Tenaya Therapeutics Announces Pricing of Underwritten Offering • GlobeNewswire Inc. • 02/08/2024 01:00:00 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 01/31/2024 09:11:23 PM
- Tenaya Therapeutics to Participate at the 42nd Annual J.P. Morgan Healthcare Conference • GlobeNewswire Inc. • 01/03/2024 01:30:00 PM
- Tenaya Therapeutics to Participate at the 35th Annual Piper Sandler Healthcare Conference • GlobeNewswire Inc. • 11/21/2023 09:30:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/08/2023 09:21:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/08/2023 09:12:49 PM
- Tenaya Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update • GlobeNewswire Inc. • 11/08/2023 09:05:00 PM
- Tenaya Therapeutics Announces FDA Clearance to Begin Clinical Testing of TN-401 Gene Therapy for the Treatment of PKP2-Associated Arrhythmogenic Right Ventricular Cardiomyopathy • GlobeNewswire Inc. • 10/26/2023 12:30:00 PM
- Tenaya Therapeutics Presents Encouraging New Clinical and Preclinical Data from HDAC6 Inhibitor Program TN-301 for the Potential Treatment of Heart Failure with Preserved Ejection Fraction at the 2023 HFSA Annual Scientific Meeting • GlobeNewswire Inc. • 10/09/2023 12:30:00 PM
- Tenaya Therapeutics Doses First Patient in the MyPeak-1™ Phase 1b Clinical Trial of TN-201 for the Treatment of MYBPC3-Associated Hypertrophic Cardiomyopathy • GlobeNewswire Inc. • 10/05/2023 12:30:00 PM
- Tenaya Therapeutics Publishes Preclinical Data in Circulation Highlighting the Clinical Potential of Cellular Reprogramming for Cardiac Regeneration • GlobeNewswire Inc. • 10/02/2023 09:30:00 PM
- Tenaya Therapeutics to Present Data for TN-301 and TN-201 at Upcoming Medical Conferences • GlobeNewswire Inc. • 09/21/2023 08:05:00 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM
ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM
Cannabix Technologies and Omega Laboratories Inc. enter Strategic Partnership to Commercialize Marijuana Breathalyzer Technology • BLO • May 16, 2024 8:13 AM